204587-95-1 Usage
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL (2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOATE,97% is used as a chiral building block for the synthesis of pharmaceuticals. Its high purity and specific stereochemistry make it a valuable component in the development of new drugs and active pharmaceutical ingredients.
Used in Agrochemical Industry:
In the agrochemical industry, TERT-BUTYL (2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOATE,97% is utilized as a chiral building block for the synthesis of agrochemicals. Its purity and stereochemistry contribute to the creation of effective and targeted agrochemical products.
Used in Fine Chemicals Industry:
TERT-BUTYL (2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOATE,97% is also used as a chiral building block in the synthesis of other fine chemicals. Its high purity ensures that the final products meet the stringent quality requirements of various applications.
It is important to handle TERT-BUTYL (2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOATE,97% with care and follow safety guidelines when using it in laboratory or industrial settings to ensure the safety of both the users and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 204587-95-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,5,8 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 204587-95:
(8*2)+(7*0)+(6*4)+(5*5)+(4*8)+(3*7)+(2*9)+(1*5)=141
141 % 10 = 1
So 204587-95-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H21NO3/c1-14(2,3)18-13(17)12(16)11(15)9-10-7-5-4-6-8-10/h4-8,11-12,16H,9,15H2,1-3H3/p+1/t11-,12+/m1/s1
204587-95-1Relevant academic research and scientific papers
An expeditious asymmetric synthesis of allophenylnorstatine
Bunnage, Mark E.,Davies, Stephen G.,Goodwin, Christopher J.,Ichihara, Osamu
, p. 3975 - 3986 (2007/10/02)
Allophenylnorstatine [APNS; (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid], a novel amino acid found in the kynostatin class of HIV-I protease inhibitors, has been prepared in 39% overall yield via a tandem conjugate addition-electrophilic hydroxylation protocol using lithium (S)-(α-methylbenzyl)benzylamide and (+)-(camphorsulfonyl)oxaziridine. An unprecedented level of molecular recognition between a homochiral β-amino enolate and a homochiral oxaziridine is identified and the importance of enolate geometry upon hydroxylation stereoselectivity is also addressed.
